# Novo Nordisk invests $22M in Clayton, NC facility expansion

Novo Nordisk will invest $22 million at its Diabetes Finished Products manufacturing facility in Clayton, North Carolina, creating 22 full-time jobs. The expansion follows a $65 million investment announced ten months earlier.

- Type: Expansion
- Announced: 2018-12-03
- Where: Clayton, Johnston County, North Carolina, United States
- Value: $22.0M
- Jobs: 22
- Status: announced
- Products: diabetes and obesity medicines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [researchtriangle.org](https://researchtriangle.org/news/danish-insulin-maker-in-johnston-county-will-invest-22-million-as-biopharma-crescent-draws-attention/), 2018-12-04: "Novo Nordisk, which employs almost 1,200 manufacturing workers in Johnston County, will invest $22 million at its Clayton facility, creating 22 full-time jobs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.